Results 131 to 140 of about 3,993,592 (301)

Vestibular Migraine-Like Syndrome in a Patient With Postttraumatic Headache and Medication-Overuse Headache

Case Reports in Otolaryngology
Vestibular migraine (VM) requires a migraine history according to ICHD-3, but recurrent vertigo may also develop in secondary headache disorders. We report a 52-year-old man who experienced persistent headache and recurrent vertigo following a traffic ...
Fumiyuki Goto, Takanobu Teramura, Shoji Kaneda, Kenji Okami, Koichiro Wasano   +4 more
doaj   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor, Stefano Comai, Gianfranco Pasut, Franco Folli, Marco Gentilucci, Negar Gharavi, Sofia Raitsin, Thuy Van Nguyen, Marco Pappagallo, Andrea Mattarei, Paolo L. Manfredi, Sara De Martin   +11 more
wiley   +1 more source

Headache, anxiety and depressive disorders: the HADAS study. J Headache Pain

, 2010
Headache, anxiety and depressive disorders: the HADAS study J Headache Pain (2010) 11:141–150 Ettore Beghi • Gennaro Bussone • Domenico D’Amico • Pietro Cortelli • Sabina Cevoli • Gian Camillo Manzoni • Paola Torelli • Maria Clara Tonini • Giovanni ...
Beghi M, Cevoli S, Moschiano F, Tonini MC, D'Amico D, D'Onofrio F, Torelli P, Allais G, Salvi S., Manzoni GC, Cortelli P, Beghi E, Bussone G, Genco S, DE SIMONE, ROBERTO   +14 more
core  

A scoping review of adverse events associated with concomitant beta‐adrenoreceptor blockers and selective serotonin reuptake inhibitors

British Journal of Clinical Pharmacology, EarlyView.
Beta‐adrenoreceptor blockers (beta‐blockers) and selective serotonin reuptake inhibitors (SSRIs) are commonly used medications and often used together, such as for the treatment of anxiety. However, there is no recent review of any potential adverse events related to concomitant use of medicines from each group.
Ziyi Cai, James Sutton, Charlotte Archer, Caroline S. Copeland, Joseph Hayes, Charles E. Leonard, Nicky Lidbetter, Kenneth K. C. Man, Faraz Mughal, Ian C. K. Wong, Hayley C. Gorton   +10 more
wiley   +1 more source

Headache symptoms consistent with migraine and tension-type headaches in children with anxiety disorders

, 2016
Objective To examine the incidence of headache symptoms consistent with migraine and tension-type headache (TTH) in children with anxiety disorders. Method.
Martin, Paul R, Martin, Paul, Waters, Allison M, Fielding, Jennifer, Young, Sarah, Waters, Allison   +5 more
core   +1 more source

Pharmacokinetic and pharmacodynamic interaction of enavogliflozin, a sodium‐glucose cotransporter 2 inhibitor, with glimepiride and metformin in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Enavogliflozin, a sodium‐glucose cotransporter 2 inhibitor, is expected to be coadministered with antihyperglycaemic drugs with different mechanisms of action. This study aimed to investigate the pharmacokinetic (PK) and pharmacodynamic (PD) interactions between enavogliflozin, glimepiride and metformin.
Kyungrin Chang, Yoonjin Kim, Daye Jung, Jae Min Cho, Joo‐Youn Cho, SeungHwan Lee   +5 more
wiley   +1 more source

Teacher confidence and student engagement with mental health and wellbeing lessons: Learning from an iterative curriculum intervention in schools

British Educational Research Journal, EarlyView.
Abstract The mental health and wellbeing of young people has received increasing attention in both research and the wider public discourse. There has been a marked rise in mental health conditions in young people, and the burden of care is increasingly transferred onto schools and teachers.
Thomas Godfrey‐Faussett, Naomi French, Abbie Simpkin, Julian Turner, Tracey Riseborough, Natalie Coles, Ian Thompson   +6 more
wiley   +1 more source

How are managed headache sufferers outside from specialized centres? A pharmaco-epidemiology report

, 2002
Headache patients employs more often OTCs (41.83%) than patients followed by the headache centre (16.45%). Only 14% of patients observed for the first time made a prophilactic treatment. Headache patients not followed by specialised care centre are often
FERRARI, Anna, Sternieri E, Cicero A.F.G.   +2 more
core  

What Proportion of Emergency Department Headache Patients With Normal Neurology Have a Serious Secondary Headache Cause? A HEAD Study Report

Objectives To estimate the proportion of Emergency Department (ED) headache patients without neurological features who are diagnosed with a serious secondary headache cause. Methods Unplanned secondary analysis of HEAD Study/HEAD Colombia data. Patients
Keijzers, Gerben, Kinnear, Frances B, Kuan, Win Sen, Chu, Kevin H, HEAD Study and HEAD Colombia Investigators, Cardozo-Ocampo, Alejandro, Kelly, Anne Maree   +6 more
core   +1 more source

Exploring the early observations of parents supporting their children with school attendance problems (SAPs): A co‐produced study

British Educational Research Journal, EarlyView.
Abstract School Attendance Problems (SAPs) represent a significant challenge requiring early identification and intervention. Current service provision often does not recognise early indicators that parents observe, creating gaps between when initial concerns are raised and formal support is provided.
Tereza Aidonopoulou‐Read, Michelle Pyer, Beth Bodycote, Jackie Campbell, Kirsteen Pyer   +4 more
wiley   +1 more source